Literature DB >> 24989407

Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging.

F Lamare1, A Le Maitre2, M Dawood3, K P Schäfers3, P Fernandez1, O E Rimoldi4, D Visvikis2.   

Abstract

PURPOSE: Cardiac imaging suffers from both respiratory and cardiac motion. One of the proposed solutions involves double gated acquisitions. Although such an approach may lead to both respiratory and cardiac motion compensation there are issues associated with (a) the combination of data from cardiac and respiratory motion bins, and (b) poor statistical quality images as a result of using only part of the acquired data. The main objective of this work was to evaluate different schemes of combining binned data in order to identify the best strategy to reconstruct motion free cardiac images from dual gated positron emission tomography (PET) acquisitions.
METHODS: A digital phantom study as well as seven human studies were used in this evaluation. PET data were acquired in list mode (LM). A real-time position management system and an electrocardiogram device were used to provide the respiratory and cardiac motion triggers registered within the LM file. Acquired data were subsequently binned considering four and six cardiac gates, or the diastole only in combination with eight respiratory amplitude gates. PET images were corrected for attenuation, but no randoms nor scatter corrections were included. Reconstructed images from each of the bins considered above were subsequently used in combination with an affine or an elastic registration algorithm to derive transformation parameters allowing the combination of all acquired data in a particular position in the cardiac and respiratory cycles. Images were assessed in terms of signal-to-noise ratio (SNR), contrast, image profile, coefficient-of-variation (COV), and relative difference of the recovered activity concentration.
RESULTS: Regardless of the considered motion compensation strategy, the nonrigid motion model performed better than the affine model, leading to higher SNR and contrast combined with a lower COV. Nevertheless, when compensating for respiration only, no statistically significant differences were observed in the performance of the two motion models considered. Superior image SNR and contrast were seen using the affine respiratory motion model in combination with the diastole cardiac bin in comparison to the use of the whole cardiac cycle. In contrast, when simultaneously correcting for cardiac beating and respiration, the elastic respiratory motion model outperformed the affine model. In this context, four cardiac bins associated with eight respiratory amplitude bins seemed to be adequate.
CONCLUSIONS: Considering the compensation of respiratory motion effects only, both affine and elastic based approaches led to an accurate resizing and positioning of the myocardium. The use of the diastolic phase combined with an affine model based respiratory motion correction may therefore be a simple approach leading to significant quality improvements in cardiac PET imaging. However, the best performance was obtained with the combined correction for both cardiac and respiratory movements considering all the dual-gated bins independently through the use of an elastic model based motion compensation.

Entities:  

Mesh:

Year:  2014        PMID: 24989407     DOI: 10.1118/1.4881099

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  Comparative analysis of iterative reconstruction algorithms with resolution recovery and time of flight modeling for 18F-FDG cardiac PET: A multi-center phantom study.

Authors:  Roberta Matheoud; Michela Lecchi; Domenico Lizio; Camilla Scabbio; Claudio Marcassa; Lucia Leva; Angelo Del Sole; Carlo Rodella; Luca Indovina; Christian Bracco; Marco Brambilla; Orazio Zoccarato
Journal:  J Nucl Cardiol       Date:  2016-01-12       Impact factor: 5.952

2.  Attenuation correction in cardiac PET: To raise awareness for a problem which is as old as PET/CT.

Authors:  Stephan G Nekolla; Axel Martinez-Möller
Journal:  J Nucl Cardiol       Date:  2015-03-12       Impact factor: 5.952

Review 3.  Motion correction options in PET/MRI.

Authors:  Ciprian Catana
Journal:  Semin Nucl Med       Date:  2015-05       Impact factor: 4.446

4.  Advances in imaging instrumentation for nuclear cardiology.

Authors:  Jae Sung Lee; Gil Kovalski; Tali Sharir; Dong Soo Lee
Journal:  J Nucl Cardiol       Date:  2017-07-17       Impact factor: 5.952

5.  Cardiac and Respiratory Motion Correction for Simultaneous Cardiac PET/MR.

Authors:  Christoph Kolbitsch; Mark A Ahlman; Cynthia Davies-Venn; Robert Evers; Michael Hansen; Devis Peressutti; Paul Marsden; Peter Kellman; David A Bluemke; Tobias Schaeffter
Journal:  J Nucl Med       Date:  2017-02-09       Impact factor: 10.057

6.  The dream of imaging coronary artery inflammation with FDG PET/CT imaging.

Authors:  R Glenn Wells; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2016-06-03       Impact factor: 5.952

Review 7.  Enhancing Cardiac PET by Motion Correction Techniques.

Authors:  Mathieu Rubeaux; Mhairi K Doris; Adam Alessio; Piotr J Slomka
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

Review 8.  Motion Correction and Its Impact on Absolute Myocardial Blood Flow Measures with PET.

Authors:  Marina Piccinelli; John R Votaw; Ernest V Garcia
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

9.  Blood pool and tissue phase patient motion effects on 82rubidium PET myocardial blood flow quantification.

Authors:  Edward P Ficaro; Venkatesh L Murthy; Benjamin C Lee; Jonathan B Moody; Alexis Poitrasson-Rivière; Amanda C Melvin; Richard L Weinberg; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-03-23       Impact factor: 5.952

10.  MR-based cardiac and respiratory motion correction of PET: application to static and dynamic cardiac 18F-FDG imaging.

Authors:  Y Petibon; T Sun; P K Han; C Ma; G El Fakhri; J Ouyang
Journal:  Phys Med Biol       Date:  2019-10-04       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.